Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY) shares gapped down prior to trading on Wednesday . The stock had previously closed at $13.80, but opened at $13.39. Terumo shares last traded at $13.3770, with a volume of 24,874 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Terumo currently has a consensus rating of “Hold”.

Terumo Stock Performance

The company’s fifty day simple moving average is $13.89 and its 200 day simple moving average is $13.57. The stock has a market capitalization of $20.03 billion, a P/E ratio of 22.26 and a beta of 0.68. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, hitting the consensus estimate of $0.11. Terumo had a net margin of 12.09% and a return on equity of 9.17%. The firm had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.84 billion. As a group, sell-side analysts forecast that Terumo Corp. will post 0.7 earnings per share for the current fiscal year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.